Researchers have uncovered a network of abnormally activated immune cells and fibroblasts — the primary active cell of connective tissue…
Articles by Steve Bryson, PhD
Findings of defects in the heart’s right ventricle, as assessed with an MRI scan, can predict the occurrence of cardiovascular…
A Phase 3 clinical trial testing the ability of efzofitimod to safely improve lung function and reduce corticosteroid usage…
Researchers have developed a highly selective and sensitive test to detect neuropilin-2 (NRP2), the therapeutic protein target of efzofitimod,…
The Foundation for Sarcoidosis Research (FSR) has awarded pulmonologist Nancy Lin, MD, at National Jewish Health, the FSR Sarcoidosis…
The Foundation for Sarcoidosis Research (FSR) has hosted a virtual session attended by people with pulmonary sarcoidosis and…
aTyr Pharma is launching a Phase 3 clinical trial to evaluate the safety and effectiveness of efzofitimod (ATYR1923) in…
The risks of death and rejection after heart transplant for people with advanced cardiac sarcoidosis were similar to those…
A protein called neurofilament light chain (NFL), which supports nerve fibers, is elevated in adults with neurosarcoidosis — and…
A rare case of sarcoidosis affecting only the spleen was successfully diagnosed using tissue analysis, after imaging…